In neurodegenerative diseases, such as Alzheimer’s disease (AD) [26,27], multiple sclerosis [28], and Parkinson’s disease (PD), the levels of TNF are increased in the post-mortem brain, serum, and cerebrospinal fluid (CSF) [29,30]. This evidence concerns the gene TNF and multiple sclerosis.